319 results on '"Naas, Thierry"'
Search Results
2. Neonatal sepsis due to NDM-1 and VIM-2 co-producing Pseudomonas aeruginosa in Morocco
3. An antiplasmid system drives antibiotic resistance gene integration in carbapenemase-producing Escherichia coli lineages
4. Accumulibacter spp. as the origin of the OXA-198 carbapenemase gene cassette
5. Combining deep learning and droplet microfluidics for rapid and label-free antimicrobial susceptibility testing of colistin
6. Spread of carbapenemase-producing Morganella spp from 2013 to 2021: a comparative genomic study
7. Development of an ultrafast PCR to detect clinically relevant acquired vancomycin-resistance genes from cultured enterococci
8. Multicenter study to assess the use of BL-DetecTool for the detection of CTX-M-type ESBLs and carbapenemases directly from clinical specimens
9. Antibiotic Susceptibility Profiles of Bacterial Isolates Recovered from Abscesses in Cattle and Sheep at a Slaughterhouse in Algeria
10. Emergence of NDM-1, VIM-4 and CTX-M-15-co-harbouring Enterobacter xiangfangensis in a bloodstream infection
11. An anti-virulence drug targeting the evolvability protein Mfd protects against infections with antimicrobial resistant ESKAPE pathogens
12. Characterization of VIM-29 and VIM-86, two VIM-1 variants isolated in multidrug-resistant Enterobacterales in France
13. The occurrence of the carbapenemase gene, blaNDM-5, on a transmissible IncX3 plasmid in Multidrug-Resistant Escherichia coli isolated from a Farm Dog
14. Multidrug-Resistant Pathogens Contaminate River Water Used in Irrigation in Disenfranchised Communities
15. The emergence of carbapenemase-producing Enterobacterales in hospitals: a major challenge for a debilitated healthcare system in Lebanon
16. Emergence of blaNDM-5-harboring Escherichia coli ST617 in refugee and host communities and their environment
17. Emergence and rapid dissemination of highly resistant NDM-14-producing Klebsiella pneumoniae ST147, France, 2022
18. Nationwide molecular epidemiology of carbapenemase-producing Citrobacter spp. in France in 2019 and 2020
19. First report of the mobile colistin resistance gene, mcr-1.26, in multidrug-resistant Escherichia coli isolated from retail chicken meat
20. Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France
21. Genomic characterization of an NDM-9-producing Acinetobacter baumannii clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9
22. An updated patent review of metallo-β-lactamase inhibitors (2020–2023)
23. In Vitro Activity of Two Novel Antimicrobial Compounds on MDR-Resistant Clinical Isolates
24. Multidrug-resistant Enterobacterales responsible for septicaemia in a neonatal intensive care unit in Morocco
25. In vitro activity of apramycin against 16S-RMTase-producing Gram-negative isolates
26. Performance evaluation of the UMIC® Cefiderocol to determine MIC in Gram-negative bacteria
27. β-Lactamase Genes without Limits
28. Diversity of genetic platforms harboring the blaPER-2 gene in Enterobacterales and insights into the role of ISPa12 in its mobilization and dissemination.
29. Prevalence of mecA and Panton-Valentine Leukocidin Genes in Staphylococcus aureus Clinical Isolates from Gaza Strip Hospitals
30. Comparative genomics of carbapenemase-producingMorganella spp
31. Genetic basis for in vivo piperacillin-tazobactam resistance
32. Rapid selection of a cefiderocol-resistantEscherichia coliproducing NDM-5 associated with a single amino acid substitution in the CirA siderophore receptor
33. Uncommon close genetic environment responsible for weak expression of blaNDM-1 in Klebsiella pneumoniae of ST147
34. Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales
35. Structural and Biochemical Features of OXA-517: a Carbapenem and Expanded-Spectrum Cephalosporin Hydrolyzing OXA-48 Variant
36. Evaluation of InTray Cassettes Directly from Blood Cultures for the Diagnosis of Sepsis in Clinical Bacteriology Laboratories as an Alternative to Classic Culture Media
37. In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales
38. Polyclonal Dissemination of OXA-232 Carbapenemase–Producing Klebsiella pneumoniae, France, 2013–2021
39. Clinical Added Value of SARS-CoV-2 Antigen Detection in Blood Samples
40. In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium
41. Susceptibility of OXA-48-producing Enterobacterales to imipenem/relebactam, meropenem/vaborbactam and ceftazidime/avibactam
42. Prevalence and Molecular Mechanisms of Carbapenem Resistance among Gram-Negative Bacilli in Three Hospitals of Northern Lebanon
43. Evaluation of the EasyScreen™ ESBL/CPO Detection Kit for the Detection of ß-Lactam Resistance Genes
44. First Detection of Carbapenemases-Producing Acinetobacter baumannii and Acinetobacter nosocomialis in Côte d’Ivoire
45. Validation of Three MicroScan® Antimicrobial Susceptibility Testing Plates Designed for Low-Resource Settings
46. Computational Modeling and Design of New Inhibitors of Carbapenemases: A Discussion from the EPIC Alliance Network
47. Rapid detection of CTX-M-type ESBLs and carbapenemases directly from biological samples using the BL-DetecTool
48. Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales
49. The Revolution of Lateral Flow Assay in the Field of AMR Detection
50. Activity of mecillinam against carbapenem-resistant Enterobacterales
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.